LP 607 (Temozolomide 140 mg)
Pill with imprint LP 607 is Blue & White, Capsule-shape and has been identified as Temozolomide 140 mg. It is supplied by Lotus Pharmaceutical Co., Ltd.
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 140 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LP 607
Temozolomide
- Imprint
- LP 607
- Strength
- 140 mg
- Color
- Blue & White
- Size
- 20.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lotus Pharmaceutical Co., Ltd.
- National Drug Code (NDC)
- 40051-0607
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
sodium starch glycolate type A corn,
tartaric acid,
gelatin,
titanium dioxide,
ferric oxide yellow,
FD&C Blue No. 2,
stearic acid
Note: Inactive ingredients may vary.
More about temozolomide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (8)
- Drug images
- Pricing & coupons
- En español
- Drug class: alkylating agents
Patient resources
- Drug Information
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
- Other brands
- Temodar
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.